nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—Methadyl Acetate—Tamoxifen—pancreatic cancer	0.0764	0.153	CrCrCtD
Modafinil—Levomethadyl Acetate—Tamoxifen—pancreatic cancer	0.0764	0.153	CrCrCtD
Modafinil—Phenoxybenzamine—Tamoxifen—pancreatic cancer	0.0627	0.126	CrCrCtD
Modafinil—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.0627	0.126	CrCrCtD
Modafinil—Methadone—Tamoxifen—pancreatic cancer	0.0524	0.105	CrCrCtD
Modafinil—Orphenadrine—Tamoxifen—pancreatic cancer	0.0439	0.0881	CrCrCtD
Modafinil—Benzphetamine—Tamoxifen—pancreatic cancer	0.0439	0.0881	CrCrCtD
Modafinil—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0407	0.0817	CrCrCtD
Modafinil—Diphenhydramine—Tamoxifen—pancreatic cancer	0.039	0.0783	CrCrCtD
Modafinil—CYP2B6—Tamoxifen—pancreatic cancer	0.0363	0.0979	CbGbCtD
Modafinil—CYP3A5—Tamoxifen—pancreatic cancer	0.0286	0.0771	CbGbCtD
Modafinil—CYP2B6—Irinotecan—pancreatic cancer	0.0279	0.0751	CbGbCtD
Modafinil—CYP1A2—Dacarbazine—pancreatic cancer	0.0268	0.0721	CbGbCtD
Modafinil—CYP3A5—Erlotinib—pancreatic cancer	0.0243	0.0655	CbGbCtD
Modafinil—CYP2C19—Tamoxifen—pancreatic cancer	0.0231	0.0622	CbGbCtD
Modafinil—CYP3A5—Irinotecan—pancreatic cancer	0.022	0.0592	CbGbCtD
Modafinil—CYP1A2—Tamoxifen—pancreatic cancer	0.0213	0.0574	CbGbCtD
Modafinil—CYP2C9—Tamoxifen—pancreatic cancer	0.0192	0.0517	CbGbCtD
Modafinil—CYP1A2—Erlotinib—pancreatic cancer	0.0181	0.0488	CbGbCtD
Modafinil—CYP3A5—Docetaxel—pancreatic cancer	0.0161	0.0434	CbGbCtD
Modafinil—CYP3A5—Sunitinib—pancreatic cancer	0.016	0.0432	CbGbCtD
Modafinil—CYP1A2—Fluorouracil—pancreatic cancer	0.0157	0.0423	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—pancreatic cancer	0.0152	0.041	CbGbCtD
Modafinil—CYP2C9—Fluorouracil—pancreatic cancer	0.0141	0.0381	CbGbCtD
Modafinil—CYP3A4—Tamoxifen—pancreatic cancer	0.0112	0.0301	CbGbCtD
Modafinil—CYP3A4—Erlotinib—pancreatic cancer	0.00949	0.0256	CbGbCtD
Modafinil—CYP3A4—Irinotecan—pancreatic cancer	0.00857	0.0231	CbGbCtD
Modafinil—CYP3A4—Docetaxel—pancreatic cancer	0.00628	0.0169	CbGbCtD
Modafinil—CYP3A4—Sunitinib—pancreatic cancer	0.00625	0.0168	CbGbCtD
Modafinil—CYP3A4—Doxorubicin—pancreatic cancer	0.00468	0.0126	CbGbCtD
Modafinil—Ketoprofen—CXCL8—pancreatic cancer	0.000291	0.286	CrCbGaD
Modafinil—Nepafenac—PTGS2—pancreatic cancer	0.000209	0.206	CrCbGaD
Modafinil—Oxaprozin—PTGS2—pancreatic cancer	0.000174	0.171	CrCbGaD
Modafinil—Fenoprofen—PTGS2—pancreatic cancer	0.000144	0.141	CrCbGaD
Modafinil—Phenylbutazone—PTGS2—pancreatic cancer	0.000115	0.113	CrCbGaD
Modafinil—Drowsiness—Epirubicin—pancreatic cancer	0.000104	0.000802	CcSEcCtD
Modafinil—Bronchitis—Doxorubicin—pancreatic cancer	0.000104	0.0008	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000103	0.000795	CcSEcCtD
Modafinil—Chest pain—Docetaxel—pancreatic cancer	0.000103	0.000791	CcSEcCtD
Modafinil—Arthralgia—Docetaxel—pancreatic cancer	0.000103	0.000791	CcSEcCtD
Modafinil—Myalgia—Docetaxel—pancreatic cancer	0.000103	0.000791	CcSEcCtD
Modafinil—Nausea—Sunitinib—pancreatic cancer	0.000103	0.000791	CcSEcCtD
Modafinil—Pancytopenia—Doxorubicin—pancreatic cancer	0.000102	0.00079	CcSEcCtD
Modafinil—Asthenia—Irinotecan—pancreatic cancer	0.000102	0.000787	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000102	0.000785	CcSEcCtD
Modafinil—Stomatitis—Epirubicin—pancreatic cancer	0.000101	0.000781	CcSEcCtD
Modafinil—Urinary tract infection—Epirubicin—pancreatic cancer	0.000101	0.000779	CcSEcCtD
Modafinil—Conjunctivitis—Epirubicin—pancreatic cancer	0.000101	0.000779	CcSEcCtD
Modafinil—Hypersensitivity—Fluorouracil—pancreatic cancer	0.0001	0.000774	CcSEcCtD
Modafinil—Dry mouth—Docetaxel—pancreatic cancer	0.0001	0.000773	CcSEcCtD
Modafinil—Sweating—Epirubicin—pancreatic cancer	9.97e-05	0.000769	CcSEcCtD
Modafinil—Pollakiuria—Doxorubicin—pancreatic cancer	9.97e-05	0.000769	CcSEcCtD
Modafinil—Asthenia—Gemcitabine—pancreatic cancer	9.94e-05	0.000766	CcSEcCtD
Modafinil—Haematuria—Epirubicin—pancreatic cancer	9.92e-05	0.000764	CcSEcCtD
Modafinil—Confusional state—Docetaxel—pancreatic cancer	9.91e-05	0.000764	CcSEcCtD
Modafinil—Photosensitivity reaction—Doxorubicin—pancreatic cancer	9.85e-05	0.000759	CcSEcCtD
Modafinil—Anaphylactic shock—Docetaxel—pancreatic cancer	9.83e-05	0.000758	CcSEcCtD
Modafinil—Oedema—Docetaxel—pancreatic cancer	9.83e-05	0.000758	CcSEcCtD
Modafinil—Weight increased—Doxorubicin—pancreatic cancer	9.82e-05	0.000757	CcSEcCtD
Modafinil—Epistaxis—Epirubicin—pancreatic cancer	9.81e-05	0.000756	CcSEcCtD
Modafinil—Pruritus—Gemcitabine—pancreatic cancer	9.8e-05	0.000756	CcSEcCtD
Modafinil—Infection—Docetaxel—pancreatic cancer	9.77e-05	0.000753	CcSEcCtD
Modafinil—Weight decreased—Doxorubicin—pancreatic cancer	9.76e-05	0.000753	CcSEcCtD
Modafinil—Sinusitis—Epirubicin—pancreatic cancer	9.76e-05	0.000752	CcSEcCtD
Modafinil—Hyperglycaemia—Doxorubicin—pancreatic cancer	9.73e-05	0.000751	CcSEcCtD
Modafinil—Diarrhoea—Irinotecan—pancreatic cancer	9.73e-05	0.00075	CcSEcCtD
Modafinil—Agranulocytosis—Epirubicin—pancreatic cancer	9.7e-05	0.000748	CcSEcCtD
Modafinil—Pneumonia—Doxorubicin—pancreatic cancer	9.68e-05	0.000746	CcSEcCtD
Modafinil—Shock—Docetaxel—pancreatic cancer	9.67e-05	0.000746	CcSEcCtD
Modafinil—Nervous system disorder—Docetaxel—pancreatic cancer	9.64e-05	0.000743	CcSEcCtD
Modafinil—Pruritus—Fluorouracil—pancreatic cancer	9.64e-05	0.000743	CcSEcCtD
Modafinil—Drowsiness—Doxorubicin—pancreatic cancer	9.62e-05	0.000742	CcSEcCtD
Modafinil—Tachycardia—Docetaxel—pancreatic cancer	9.6e-05	0.00074	CcSEcCtD
Modafinil—Skin disorder—Docetaxel—pancreatic cancer	9.55e-05	0.000736	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	9.54e-05	0.000735	CcSEcCtD
Modafinil—Bradycardia—Epirubicin—pancreatic cancer	9.5e-05	0.000733	CcSEcCtD
Modafinil—Diarrhoea—Gemcitabine—pancreatic cancer	9.48e-05	0.000731	CcSEcCtD
Modafinil—Dizziness—Irinotecan—pancreatic cancer	9.41e-05	0.000725	CcSEcCtD
Modafinil—Stomatitis—Doxorubicin—pancreatic cancer	9.38e-05	0.000723	CcSEcCtD
Modafinil—Anorexia—Docetaxel—pancreatic cancer	9.37e-05	0.000723	CcSEcCtD
Modafinil—Rhinitis—Epirubicin—pancreatic cancer	9.36e-05	0.000722	CcSEcCtD
Modafinil—Urinary tract infection—Doxorubicin—pancreatic cancer	9.35e-05	0.000721	CcSEcCtD
Modafinil—Conjunctivitis—Doxorubicin—pancreatic cancer	9.35e-05	0.000721	CcSEcCtD
Modafinil—Diarrhoea—Fluorouracil—pancreatic cancer	9.32e-05	0.000719	CcSEcCtD
Modafinil—Pharyngitis—Epirubicin—pancreatic cancer	9.27e-05	0.000714	CcSEcCtD
Modafinil—Sweating—Doxorubicin—pancreatic cancer	9.22e-05	0.000711	CcSEcCtD
Modafinil—Urinary tract disorder—Epirubicin—pancreatic cancer	9.22e-05	0.000711	CcSEcCtD
Modafinil—Oedema peripheral—Epirubicin—pancreatic cancer	9.2e-05	0.000709	CcSEcCtD
Modafinil—Hypotension—Docetaxel—pancreatic cancer	9.19e-05	0.000708	CcSEcCtD
Modafinil—Haematuria—Doxorubicin—pancreatic cancer	9.17e-05	0.000707	CcSEcCtD
Modafinil—Connective tissue disorder—Epirubicin—pancreatic cancer	9.17e-05	0.000707	CcSEcCtD
Modafinil—Urethral disorder—Epirubicin—pancreatic cancer	9.15e-05	0.000706	CcSEcCtD
Modafinil—Epistaxis—Doxorubicin—pancreatic cancer	9.08e-05	0.0007	CcSEcCtD
Modafinil—Vomiting—Irinotecan—pancreatic cancer	9.04e-05	0.000697	CcSEcCtD
Modafinil—Sinusitis—Doxorubicin—pancreatic cancer	9.03e-05	0.000696	CcSEcCtD
Modafinil—Dizziness—Fluorouracil—pancreatic cancer	9.01e-05	0.000695	CcSEcCtD
Modafinil—Visual impairment—Epirubicin—pancreatic cancer	9e-05	0.000694	CcSEcCtD
Modafinil—Agranulocytosis—Doxorubicin—pancreatic cancer	8.98e-05	0.000692	CcSEcCtD
Modafinil—Rash—Irinotecan—pancreatic cancer	8.97e-05	0.000691	CcSEcCtD
Modafinil—Dermatitis—Irinotecan—pancreatic cancer	8.96e-05	0.000691	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	8.96e-05	0.000691	CcSEcCtD
Modafinil—Headache—Irinotecan—pancreatic cancer	8.91e-05	0.000687	CcSEcCtD
Modafinil—Insomnia—Docetaxel—pancreatic cancer	8.89e-05	0.000686	CcSEcCtD
Modafinil—Paraesthesia—Docetaxel—pancreatic cancer	8.83e-05	0.000681	CcSEcCtD
Modafinil—Erythema multiforme—Epirubicin—pancreatic cancer	8.83e-05	0.000681	CcSEcCtD
Modafinil—Vomiting—Gemcitabine—pancreatic cancer	8.81e-05	0.000679	CcSEcCtD
Modafinil—Bradycardia—Doxorubicin—pancreatic cancer	8.79e-05	0.000678	CcSEcCtD
Modafinil—Dyspnoea—Docetaxel—pancreatic cancer	8.77e-05	0.000676	CcSEcCtD
Modafinil—Somnolence—Docetaxel—pancreatic cancer	8.74e-05	0.000674	CcSEcCtD
Modafinil—Rash—Gemcitabine—pancreatic cancer	8.74e-05	0.000674	CcSEcCtD
Modafinil—Dermatitis—Gemcitabine—pancreatic cancer	8.73e-05	0.000673	CcSEcCtD
Modafinil—Headache—Gemcitabine—pancreatic cancer	8.68e-05	0.000669	CcSEcCtD
Modafinil—Cardiac disorder—Epirubicin—pancreatic cancer	8.66e-05	0.000668	CcSEcCtD
Modafinil—Vomiting—Fluorouracil—pancreatic cancer	8.66e-05	0.000668	CcSEcCtD
Modafinil—Rhinitis—Doxorubicin—pancreatic cancer	8.66e-05	0.000668	CcSEcCtD
Modafinil—Dyspepsia—Docetaxel—pancreatic cancer	8.66e-05	0.000667	CcSEcCtD
Modafinil—Rash—Fluorouracil—pancreatic cancer	8.59e-05	0.000662	CcSEcCtD
Modafinil—Dermatitis—Fluorouracil—pancreatic cancer	8.58e-05	0.000662	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—pancreatic cancer	8.57e-05	0.000661	CcSEcCtD
Modafinil—Decreased appetite—Docetaxel—pancreatic cancer	8.55e-05	0.000659	CcSEcCtD
Modafinil—Headache—Fluorouracil—pancreatic cancer	8.53e-05	0.000658	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—pancreatic cancer	8.53e-05	0.000658	CcSEcCtD
Modafinil—Oedema peripheral—Doxorubicin—pancreatic cancer	8.51e-05	0.000656	CcSEcCtD
Modafinil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	8.49e-05	0.000655	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—pancreatic cancer	8.49e-05	0.000654	CcSEcCtD
Modafinil—Fatigue—Docetaxel—pancreatic cancer	8.48e-05	0.000654	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—pancreatic cancer	8.48e-05	0.0834	CrCbGaD
Modafinil—Angiopathy—Epirubicin—pancreatic cancer	8.47e-05	0.000653	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—pancreatic cancer	8.47e-05	0.000653	CcSEcCtD
Modafinil—Nausea—Irinotecan—pancreatic cancer	8.45e-05	0.000651	CcSEcCtD
Modafinil—Immune system disorder—Epirubicin—pancreatic cancer	8.43e-05	0.00065	CcSEcCtD
Modafinil—Mediastinal disorder—Epirubicin—pancreatic cancer	8.41e-05	0.000649	CcSEcCtD
Modafinil—Pain—Docetaxel—pancreatic cancer	8.41e-05	0.000648	CcSEcCtD
Modafinil—Constipation—Docetaxel—pancreatic cancer	8.41e-05	0.000648	CcSEcCtD
Modafinil—Chills—Epirubicin—pancreatic cancer	8.38e-05	0.000646	CcSEcCtD
Modafinil—Arrhythmia—Epirubicin—pancreatic cancer	8.34e-05	0.000643	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—pancreatic cancer	8.32e-05	0.000642	CcSEcCtD
Modafinil—Nausea—Gemcitabine—pancreatic cancer	8.23e-05	0.000635	CcSEcCtD
Modafinil—Mental disorder—Epirubicin—pancreatic cancer	8.18e-05	0.000631	CcSEcCtD
Modafinil—Erythema multiforme—Doxorubicin—pancreatic cancer	8.17e-05	0.00063	CcSEcCtD
Modafinil—Malnutrition—Epirubicin—pancreatic cancer	8.13e-05	0.000627	CcSEcCtD
Modafinil—Feeling abnormal—Docetaxel—pancreatic cancer	8.1e-05	0.000625	CcSEcCtD
Modafinil—Nausea—Fluorouracil—pancreatic cancer	8.09e-05	0.000624	CcSEcCtD
Modafinil—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.04e-05	0.00062	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—pancreatic cancer	8.02e-05	0.000618	CcSEcCtD
Modafinil—Flatulence—Epirubicin—pancreatic cancer	8.01e-05	0.000617	CcSEcCtD
Modafinil—Tension—Epirubicin—pancreatic cancer	7.97e-05	0.000615	CcSEcCtD
Modafinil—Dysgeusia—Epirubicin—pancreatic cancer	7.96e-05	0.000614	CcSEcCtD
Modafinil—Nervousness—Epirubicin—pancreatic cancer	7.89e-05	0.000609	CcSEcCtD
Modafinil—Back pain—Epirubicin—pancreatic cancer	7.86e-05	0.000606	CcSEcCtD
Modafinil—Angiopathy—Doxorubicin—pancreatic cancer	7.84e-05	0.000604	CcSEcCtD
Modafinil—Muscle spasms—Epirubicin—pancreatic cancer	7.81e-05	0.000602	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—pancreatic cancer	7.8e-05	0.000602	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—pancreatic cancer	7.78e-05	0.0006	CcSEcCtD
Modafinil—Body temperature increased—Docetaxel—pancreatic cancer	7.77e-05	0.000599	CcSEcCtD
Modafinil—Abdominal pain—Docetaxel—pancreatic cancer	7.77e-05	0.000599	CcSEcCtD
Modafinil—Chills—Doxorubicin—pancreatic cancer	7.75e-05	0.000598	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—pancreatic cancer	7.72e-05	0.000595	CcSEcCtD
Modafinil—Mental disorder—Doxorubicin—pancreatic cancer	7.57e-05	0.000583	CcSEcCtD
Modafinil—Ill-defined disorder—Epirubicin—pancreatic cancer	7.54e-05	0.000581	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—pancreatic cancer	7.52e-05	0.00058	CcSEcCtD
Modafinil—Anaemia—Epirubicin—pancreatic cancer	7.51e-05	0.000579	CcSEcCtD
Modafinil—Agitation—Epirubicin—pancreatic cancer	7.47e-05	0.000576	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—pancreatic cancer	7.41e-05	0.000571	CcSEcCtD
Modafinil—Tension—Doxorubicin—pancreatic cancer	7.38e-05	0.000569	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—pancreatic cancer	7.36e-05	0.000568	CcSEcCtD
Modafinil—Malaise—Epirubicin—pancreatic cancer	7.33e-05	0.000565	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—pancreatic cancer	7.3e-05	0.000563	CcSEcCtD
Modafinil—Vertigo—Epirubicin—pancreatic cancer	7.3e-05	0.000563	CcSEcCtD
Modafinil—Syncope—Epirubicin—pancreatic cancer	7.29e-05	0.000562	CcSEcCtD
Modafinil—Back pain—Doxorubicin—pancreatic cancer	7.27e-05	0.000561	CcSEcCtD
Modafinil—Hypersensitivity—Docetaxel—pancreatic cancer	7.24e-05	0.000559	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—pancreatic cancer	7.23e-05	0.000557	CcSEcCtD
Modafinil—Palpitations—Epirubicin—pancreatic cancer	7.18e-05	0.000554	CcSEcCtD
Modafinil—Loss of consciousness—Epirubicin—pancreatic cancer	7.14e-05	0.000551	CcSEcCtD
Modafinil—Cough—Epirubicin—pancreatic cancer	7.09e-05	0.000547	CcSEcCtD
Modafinil—Asthenia—Docetaxel—pancreatic cancer	7.06e-05	0.000544	CcSEcCtD
Modafinil—Convulsion—Epirubicin—pancreatic cancer	7.04e-05	0.000543	CcSEcCtD
Modafinil—Hypertension—Epirubicin—pancreatic cancer	7.02e-05	0.000541	CcSEcCtD
Modafinil—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.98e-05	0.000538	CcSEcCtD
Modafinil—Pruritus—Docetaxel—pancreatic cancer	6.96e-05	0.000536	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—pancreatic cancer	6.95e-05	0.000536	CcSEcCtD
Modafinil—Arthralgia—Epirubicin—pancreatic cancer	6.92e-05	0.000533	CcSEcCtD
Modafinil—Myalgia—Epirubicin—pancreatic cancer	6.92e-05	0.000533	CcSEcCtD
Modafinil—Chest pain—Epirubicin—pancreatic cancer	6.92e-05	0.000533	CcSEcCtD
Modafinil—Agitation—Doxorubicin—pancreatic cancer	6.91e-05	0.000533	CcSEcCtD
Modafinil—Anxiety—Epirubicin—pancreatic cancer	6.89e-05	0.000532	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.87e-05	0.00053	CcSEcCtD
Modafinil—Discomfort—Epirubicin—pancreatic cancer	6.84e-05	0.000527	CcSEcCtD
Modafinil—Malaise—Doxorubicin—pancreatic cancer	6.78e-05	0.000523	CcSEcCtD
Modafinil—Dry mouth—Epirubicin—pancreatic cancer	6.77e-05	0.000522	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—pancreatic cancer	6.76e-05	0.000521	CcSEcCtD
Modafinil—Syncope—Doxorubicin—pancreatic cancer	6.74e-05	0.00052	CcSEcCtD
Modafinil—Diarrhoea—Docetaxel—pancreatic cancer	6.73e-05	0.000519	CcSEcCtD
Modafinil—Confusional state—Epirubicin—pancreatic cancer	6.69e-05	0.000516	CcSEcCtD
Modafinil—Palpitations—Doxorubicin—pancreatic cancer	6.64e-05	0.000512	CcSEcCtD
Modafinil—Oedema—Epirubicin—pancreatic cancer	6.63e-05	0.000511	CcSEcCtD
Modafinil—Anaphylactic shock—Epirubicin—pancreatic cancer	6.63e-05	0.000511	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—pancreatic cancer	6.61e-05	0.00051	CcSEcCtD
Modafinil—Infection—Epirubicin—pancreatic cancer	6.59e-05	0.000508	CcSEcCtD
Modafinil—Cough—Doxorubicin—pancreatic cancer	6.56e-05	0.000506	CcSEcCtD
Modafinil—Shock—Epirubicin—pancreatic cancer	6.53e-05	0.000503	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—pancreatic cancer	6.51e-05	0.000502	CcSEcCtD
Modafinil—Nervous system disorder—Epirubicin—pancreatic cancer	6.5e-05	0.000501	CcSEcCtD
Modafinil—Dizziness—Docetaxel—pancreatic cancer	6.5e-05	0.000501	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—pancreatic cancer	6.49e-05	0.000501	CcSEcCtD
Modafinil—Tachycardia—Epirubicin—pancreatic cancer	6.47e-05	0.000499	CcSEcCtD
Modafinil—Skin disorder—Epirubicin—pancreatic cancer	6.44e-05	0.000497	CcSEcCtD
Modafinil—Hyperhidrosis—Epirubicin—pancreatic cancer	6.41e-05	0.000494	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—pancreatic cancer	6.4e-05	0.000494	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—pancreatic cancer	6.4e-05	0.000494	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—pancreatic cancer	6.4e-05	0.000494	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—pancreatic cancer	6.38e-05	0.000492	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.36e-05	0.00049	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—pancreatic cancer	6.32e-05	0.000488	CcSEcCtD
Modafinil—Anorexia—Epirubicin—pancreatic cancer	6.32e-05	0.000487	CcSEcCtD
Modafinil—Dry mouth—Doxorubicin—pancreatic cancer	6.26e-05	0.000483	CcSEcCtD
Modafinil—Vomiting—Docetaxel—pancreatic cancer	6.25e-05	0.000482	CcSEcCtD
Modafinil—Rash—Docetaxel—pancreatic cancer	6.2e-05	0.000478	CcSEcCtD
Modafinil—Hypotension—Epirubicin—pancreatic cancer	6.2e-05	0.000478	CcSEcCtD
Modafinil—Dermatitis—Docetaxel—pancreatic cancer	6.19e-05	0.000478	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—pancreatic cancer	6.19e-05	0.000477	CcSEcCtD
Modafinil—Headache—Docetaxel—pancreatic cancer	6.16e-05	0.000475	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.14e-05	0.000473	CcSEcCtD
Modafinil—Oedema—Doxorubicin—pancreatic cancer	6.14e-05	0.000473	CcSEcCtD
Modafinil—Infection—Doxorubicin—pancreatic cancer	6.1e-05	0.00047	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.04e-05	0.000466	CcSEcCtD
Modafinil—Shock—Doxorubicin—pancreatic cancer	6.04e-05	0.000465	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—pancreatic cancer	6.02e-05	0.000464	CcSEcCtD
Modafinil—Insomnia—Epirubicin—pancreatic cancer	6e-05	0.000462	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—pancreatic cancer	5.99e-05	0.000462	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—pancreatic cancer	5.96e-05	0.00046	CcSEcCtD
Modafinil—Paraesthesia—Epirubicin—pancreatic cancer	5.96e-05	0.000459	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.93e-05	0.000457	CcSEcCtD
Modafinil—Dyspnoea—Epirubicin—pancreatic cancer	5.91e-05	0.000456	CcSEcCtD
Modafinil—Somnolence—Epirubicin—pancreatic cancer	5.9e-05	0.000455	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—pancreatic cancer	5.85e-05	0.000451	CcSEcCtD
Modafinil—Nausea—Docetaxel—pancreatic cancer	5.84e-05	0.00045	CcSEcCtD
Modafinil—Dyspepsia—Epirubicin—pancreatic cancer	5.84e-05	0.00045	CcSEcCtD
Modafinil—Decreased appetite—Epirubicin—pancreatic cancer	5.77e-05	0.000445	CcSEcCtD
Modafinil—Hypotension—Doxorubicin—pancreatic cancer	5.73e-05	0.000442	CcSEcCtD
Modafinil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.73e-05	0.000441	CcSEcCtD
Modafinil—Fatigue—Epirubicin—pancreatic cancer	5.72e-05	0.000441	CcSEcCtD
Modafinil—Pain—Epirubicin—pancreatic cancer	5.67e-05	0.000437	CcSEcCtD
Modafinil—Constipation—Epirubicin—pancreatic cancer	5.67e-05	0.000437	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.59e-05	0.000431	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—pancreatic cancer	5.55e-05	0.000428	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—pancreatic cancer	5.51e-05	0.000425	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—pancreatic cancer	5.47e-05	0.000422	CcSEcCtD
Modafinil—Feeling abnormal—Epirubicin—pancreatic cancer	5.47e-05	0.000421	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—pancreatic cancer	5.46e-05	0.000421	CcSEcCtD
Modafinil—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.42e-05	0.000418	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—pancreatic cancer	5.4e-05	0.000416	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—pancreatic cancer	5.33e-05	0.000411	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.3e-05	0.000408	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—pancreatic cancer	5.29e-05	0.000408	CcSEcCtD
Modafinil—Urticaria—Epirubicin—pancreatic cancer	5.27e-05	0.000406	CcSEcCtD
Modafinil—Pain—Doxorubicin—pancreatic cancer	5.25e-05	0.000405	CcSEcCtD
Modafinil—Constipation—Doxorubicin—pancreatic cancer	5.25e-05	0.000405	CcSEcCtD
Modafinil—Abdominal pain—Epirubicin—pancreatic cancer	5.24e-05	0.000404	CcSEcCtD
Modafinil—Body temperature increased—Epirubicin—pancreatic cancer	5.24e-05	0.000404	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—pancreatic cancer	5.06e-05	0.00039	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.02e-05	0.000387	CcSEcCtD
Modafinil—Hypersensitivity—Epirubicin—pancreatic cancer	4.89e-05	0.000377	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—pancreatic cancer	4.88e-05	0.000376	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—pancreatic cancer	4.85e-05	0.000374	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—pancreatic cancer	4.85e-05	0.000374	CcSEcCtD
Modafinil—Asthenia—Epirubicin—pancreatic cancer	4.76e-05	0.000367	CcSEcCtD
Modafinil—Pruritus—Epirubicin—pancreatic cancer	4.69e-05	0.000362	CcSEcCtD
Modafinil—Diarrhoea—Epirubicin—pancreatic cancer	4.54e-05	0.00035	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—pancreatic cancer	4.52e-05	0.000349	CcSEcCtD
Modafinil—Asthenia—Doxorubicin—pancreatic cancer	4.4e-05	0.000339	CcSEcCtD
Modafinil—Dizziness—Epirubicin—pancreatic cancer	4.39e-05	0.000338	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—pancreatic cancer	4.34e-05	0.000335	CcSEcCtD
Modafinil—Vomiting—Epirubicin—pancreatic cancer	4.22e-05	0.000325	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—pancreatic cancer	4.2e-05	0.000324	CcSEcCtD
Modafinil—Rash—Epirubicin—pancreatic cancer	4.18e-05	0.000322	CcSEcCtD
Modafinil—Dermatitis—Epirubicin—pancreatic cancer	4.18e-05	0.000322	CcSEcCtD
Modafinil—Headache—Epirubicin—pancreatic cancer	4.15e-05	0.00032	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—pancreatic cancer	4.06e-05	0.000313	CcSEcCtD
Modafinil—Nausea—Epirubicin—pancreatic cancer	3.94e-05	0.000304	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—pancreatic cancer	3.9e-05	0.000301	CcSEcCtD
Modafinil—Rash—Doxorubicin—pancreatic cancer	3.87e-05	0.000298	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—pancreatic cancer	3.87e-05	0.000298	CcSEcCtD
Modafinil—Headache—Doxorubicin—pancreatic cancer	3.84e-05	0.000296	CcSEcCtD
Modafinil—Nausea—Doxorubicin—pancreatic cancer	3.65e-05	0.000281	CcSEcCtD
